Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Source-aware microbial–host signaling after ischemic stroke: evidence, competing origins, and causal roles

4 affiliations
  1. 1Tianjin University of Traditional Chinese Medicine
  2. 2Shanxi University of Traditional Chinese Medicine, Jinzhong
  3. 3Shandong University of Traditional Chinese Medicine, Jinan
  4. 4Encephalopathy Acupuncture Center 2, The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

Abstract

Ischemic stroke initiates a well-established sterile inflammatory response in injured brain tissue. Experimental studies report post-stroke intestinal barrier and mucosal changes, viable bacterial dissemination to peripheral compartments in selected animal models, and microbiota-associated material in ischemic brain tissue. Human cohorts associate gut community or metabolite profiles with infection and clinical outcomes, while microbiome-based models predict stroke-associated pneumonia or functional outcomes. These observations differ in signal identity, sampling time, source tracing, and measured destination. Gut-to-periphery dissemination in one model does not establish that brain-associated signals are viable or intestinal in origin; oral, airway, aspiration-related, infectious, and other peripheral sources remain plausible. This narrative Review synthesizes human and experimental evidence across five connected links: anatomical source, molecular identity, transport route, receptor or sensing cell, and tissue consequence. We distinguish transport from recognition and source attribution from causal-role assignment. Current evidence supports context-dependent intestinal participation and established brain-derived damage-associated molecular pattern (DAMP) signaling, but not a universal gut-to-brain causal cascade. We outline longitudinal source-to-target sampling, barrier and exposure measurements, signal-specific tracing, and timed perturbation to test each link.

Related

  1. Epigenetic regulation of immune checkpoint signaling by microbial metabolites: mechanisms, therapeutic potential, and future perspectives
    Asiya Nazir, Rafia Nazir, Sarika Sharma +2
    Frontiers in immunologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCCrossref
  2. Ginsenoside Rg1 for ischemic heart disease injury: preclinical evidence and possible mechanisms
    Jiaxin Chen, Sanjian Hu, Yujie Zhang +2
    Journal of Ginseng ResearchPeer-reviewedCC BYFull textMolecular biology & gene regulationDOAJEurope PMCPMC
  3. Beyond Parent-Compound Removal: Microbial Transformation Pathways, Physiological Constraints, and Evidence Integration for Environmental Steroid Hormones.
    Tianyu Zhang, Xiaolu Liu, Tong Zhou +6
    MicroorganismsPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  4. Microbial-derived metabolites in cancer: evidence boundaries, immune mechanisms and translational pathways
    Xuefeng Shi, Shunjun Wang, Wenhao Ouyang
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMCCrossrefEurope PMC
  5. Gut microbial immunometabolic pathways associated with cardiac arrest risk: genetic evidence and exploratory fecal microbiome profiling
    Liuyang Xie, Yuepeng Hu, Keke Du +5
    Frontiers in Cell and Developmental BiologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
BibTeX
@article{zhao2026sourceaware,
  title = {{Source-aware microbial–host signaling after ischemic stroke: evidence, competing origins, and causal roles}},
  author = {Xinwei Zhao and Wanyi Zhang and Zeyu Yang and Zhengyuan Liu and Linlin Zhang and Zelin Chen},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1986786},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1986786/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Source-aware microbial–host signaling after ischemic stroke: evidence, competing origins, and causal roles
AU  - Xinwei Zhao
AU  - Wanyi Zhang
AU  - Zeyu Yang
AU  - Zhengyuan Liu
AU  - Linlin Zhang
AU  - Zelin Chen
PY  - 2026
DA  - 2026/10/19
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1986786
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1986786/full
AB  - Ischemic stroke initiates a well-established sterile inflammatory response in injured brain tissue. Experimental studies report post-stroke intestinal barrier and mucosal changes, viable bacterial dissemination to peripheral compartments in selected animal models, and microbiota-associated material in ischemic brain tissue. Human cohorts associate gut community or metabolite profiles with infection and clinical outcomes, while microbiome-based models predict stroke-associated pneumonia or functional outcomes. These observations differ in signal identity, sampling time, source tracing, and measured destination. Gut-to-periphery dissemination in one model does not establish that brain-associated signals are viable or intestinal in origin; oral, airway, aspiration-related, infectious, and other peripheral sources remain plausible. This narrative Review synthesizes human and experimental evidence across five connected links: anatomical source, molecular identity, transport route, receptor or sensing cell, and tissue consequence. We distinguish transport from recognition and source attribution from causal-role assignment. Current evidence supports context-dependent intestinal participation and established brain-derived damage-associated molecular pattern (DAMP) signaling, but not a universal gut-to-brain causal cascade. We outline longitudinal source-to-target sampling, barrier and exposure measurements, signal-specific tracing, and timed perturbation to test each link.
SN  - 1664-3224
ER  -